This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Groups

Dr. rer. nat. Ralf Amann:

Scientific Career History

Since 2019        Managing Partner & CEO of Prime Vector Technologies GmbH, a spin-off from the University Hospital of Tübingen, Germany
Since 2014      Group leader „Orf Virus Vector Vaccines“, University Hospital of Tübingen, Department of Immunology, Germany
2014     PhD, Dr. rer. nat. University Hospital of Tübingen, Germany -  Department of Immunology (Prof. Dr. Hans-Georg Rammensee)
2008 - 2014   Research Fellow, University Hospital of Tübingen, Department of Immunology (Prof. Dr. Hans-Georg Rammensee), Germany
  Research Fellow, Friedrich-Loeffler-Institut, Institute for Immunology, Germany
2008          Diploma Thesis (Immunology, human genetics), Eberhard Karls Universität Tübingen, Germany
2002 – 2008        Studies of Biology, Eberhard Karls Universität Tübingen, Germany
  Studies of Biology, Universitetet i Oslo, Norway

Grants and Awards:

2018 – 2023      EXIST Research Transfer, Federal Ministry for Economic Affairs and Energy
2019    Designation as DKTK Investigator, German Cancer Consortium
2017 & 2020   Awardee „Science4Life Venture Cup”, Science4Life e.V.
2014 – 2019     Collaboration on ORFV-based Cancer Vaccines, Boehringer Ingelheim
2013 & 2016     Awardee „Science2Start“ Idea Competition, BioRegio STERN Management GMbH
2014 – 2016         ORFV-based vaccines against HPV-induced Tumors, Innovation fund, Excellence Initiative University of Tübingen
2012 – 2016    Individualized Vaccines using a viral vector, Innovation Academy GO-Bio, Federal ministry of Education and Research

 

Dr. rer. nat. Hanns-Joachim Rziha:

Scientific Career History

Since 2012   Guest Scientist at the Department of Immunology, Univ. Tübingen,
Collaboration on ORFV virus vector vaccine
1978 – 08/2014 Guest Scientist at the Department of Immunology, Univ. Tübingen,
Collaboration on ORFV virus vector vaccine
1978  Scientific Director,
Friedrich-Loeffler Institute (moved to the Island of Riems, Germany end of December 2011)
1978  PhD, Dr. rer. nat. University Erlangen-Nürnberg, Germany
Institute for Clinical Virology, (Prof. Dr. h.c. mult. Harald zur Hausen)
1975 – 1977  Research Fellow, Institute for Clinical Virology, University Erlangen-Nürnberg, Germany, (Head: Prof. Dr. h.c. mult. Harald zur Hausen)
1974 Diploma Thesis, Institute for Clinical Virology, University Erlangen-Nürnberg, Germany, (Head: Prof. Dr. h.c. mult. Harald zur Hausen)
1968 – 1974 Studies of Biology,  Friedrich-Alexander University Erlangen-Nürnberg, Germany